H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $10.00 price target on Aquestive Therapeutics (NASDAQ: AQST).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments